جستجوی استاد راهنمای دانشگاهی

Dr. Chris Gray is an Associate Professor in the Department of Medicine and a practicing cardiologist within the Division of Cardiology at Dalhousie University’s Faculty of Medicine. He is based at the QEII Health Sciences Centre in Halifax, Nova Scotia, where he provides clinical care and leads educational initiatives in cardiology and electrophysiology. His primary research interests include: Cardiac electrophysiology and arrhythmia management Atrial and ventricular fibrillation Catheter ablation techniques Inherited heart diseases Medical education and training program development Cardiac implanted electronic devices Dr. Gray's scholarly work focuses on advancing electrophysiology practices, improving training frameworks for cardiology fellows, and evaluating clinical outcomes in arrhythmia interventions. His recent publications highlight innovations in ablation technology, diagnostic pacing maneuvers, and population-level benefits of preventive device therapy. His contributions to medical education have been widely recognized through awards and leadership roles: Director of Education, Department of Medicine (2014–present) Assistant Program Director, Cardiology Residency Training Organizer of the Annual Cardiology Residents Pacemaker Course Recipient of the Cardiology Residents Teaching Award (2012) and Pfizer Award of Excellence (2007) He is actively involved in teaching across undergraduate and postgraduate levels, including PIER 4 lectures, ECG rounds, simulation training, and bedside teaching in the EP lab and intensive care units. He also serves as Secretary of the Canadian Heart Rhythm Society Executive. His laboratory and clinical team focus on arrhythmia assessment, electrophysiology procedures, and resident education, contributing to both patient care and academic advancement in cardiac rhythm disorders.

• Cardiac Electrophysiology
• Arrhythmia Management
• Medical Education
• +۷ مورد دیگر

Ronald M Peshock is a Professor of Radiology and Internal Medicine at the University of Texas Southwestern Medical Center (UTSW), with a career spanning over four decades since completing medical school at UT Southwestern in 1976. His academic journey includes Internal Medicine training at Parkland Health & Hospital System (internship 1977, residency 1979) followed by a Cardiology fellowship (1982). Dr. Peshock's research focuses on cardiac imaging, particularly using MRI and CT technologies to assess cardiovascular risk and disease. His work heavily involves the Dallas Heart Study, examining left ventricular hypertrophy, atherosclerosis, and cardiovascular risk factors across diverse populations. In recent years, he has become a prominent researcher in artificial intelligence applications for radiology, with numerous publications on AI implementation in clinical workflows, diagnostic accuracy improvement, and integration of AI into radiology training programs. His publication record shows consistent productivity from 1979 through 2025, with 218 total publications according to available records. Recent work demonstrates particular expertise in cardiac CT, pulmonary embolism imaging, and developing quantitative imaging biomarkers for cardiovascular disease. His Scopus profile indicates an h-index of 67 with 14,914 citations, reflecting significant scholarly impact in his fields. Dr. Peshock maintains active clinical and research affiliations with Parkland Health & Hospital System and serves as a key researcher in the Dallas Heart Study. His work examining ethnic differences in cardiovascular disease, left ventricular hypertrophy patterns, and aortic stiffness has contributed significantly to cardiovascular imaging literature.

• Cardiac Imaging
• Magnetic Resonance Imaging
• Computed Tomography
• +۶ مورد دیگر

Professor Antonio Dello Russo is a full faculty member at the Università Politecnica delle Marche (UNIVPM), affiliated with the School of Medicine and Surgery. He serves as a leading expert in cardiovascular diseases within the Clinic of Cardiology and Electrophysiology. His research focuses on heart rhythm disorders, clinical cardiology, and cardiovascular medicine, with a specialization in electrophysiology and pacemaker/defibrillator technology. He maintains regular office hours for student consultations. Contact: Email: a.dellorusso@univpm.it Address: Ospedali Riuniti 'Umberto I - Lancisi - Salesi', via Conca 71, 60126 Ancona (AN) Phone: 0715965798

• Cardiology
• Heart Rhythm Disorders
• Cardiovascular Diseases
• +۳ مورد دیگر

Damu Radhakrishnan is an Associate Professor in the Department of Computer Engineering at SUNY New Paltz. He holds a Ph.D. in Electrical Engineering from the University of Idaho, following B.Sc. and M.Tech. degrees from the University of Kerala and IIT Kanpur, India. His research focuses on low-power digital architectures, high-performance arithmetic circuits, reversible logic, and bio-medical instrumentation. He teaches courses including Introduction to Engineering Science, Digital Logic Lab, Digital Systems Design, and Senior Design Project 2. Dr. Radhakrishnan has contributed to over 20 publications since 1983, emphasizing low-power circuit design, residue arithmetic, and biomedical device development. His work spans analog-to-residue converters, fault-tolerant systems, and medical instrumentation. Key technical reports include contributions to NASA Langley Research Center and EG&G Corporation projects. His research trends reflect a sustained focus on energy-efficient digital systems, with early contributions to CMOS power optimization and later advancements in biomedical device testing. His publications demonstrate expertise in both theoretical foundations (e.g., switching theory textbooks) and applied engineering (e.g., defibrillator analyzers). Dr. Radhakrishnan maintains an active lab in Resnick Engineering Hall, where he oversees senior design projects and collaborates on interdisciplinary engineering solutions. His technical reports highlight contributions to medical simulation tools, VLSI implementation methods, and analog-digital interface design.

• Low Power Digital Architectures
• High-Performance Arithmetic Circuits
• Reversible Logic
• +۳ مورد دیگر

Jacqueline Joza, MD is an Assistant Professor in the Department of Medicine at McGill University's Faculty of Medicine and Health Sciences. She serves as an Investigator at the Research Institute of the McGill University Health Centre (RI-MUHC) and is affiliated with the Department of Medicine, Division of Cardiology at the McGill University Health Centre (MUHC). Dr. Joza is a member of the Cardiovascular Health Across the Lifespan Program at RI-MUHC, which focuses on comprehensive cardiovascular care throughout all stages of life. Dr. Joza's research spans multiple cutting-edge areas within cardiac electrophysiology. Her primary interests include cardiac resynchronization therapy optimization , conduction system pacing techniques , management of inherited arrhythmia syndromes including Long QT syndrome, and atrial fibrillation treatment strategies . Her work bridges clinical practice with research innovation, particularly in the areas of left bundle branch area pacing, risk stratification for arrhythmic events, and novel approaches to cardiac rhythm management. She has made significant contributions to clinical guidelines and consensus statements in the field of cardiac electrophysiology through collaborations with major cardiology societies. Dr. Joza has been actively involved in numerous clinical studies examining cardiac pacing technologies, arrhythmia management, and outcomes research in electrophysiology procedures. Her research often combines clinical observation with advanced analytical approaches, including in silico modeling of cardiac electrophysiology and vectorcardiographic analysis. She has published extensively on topics related to cardiac device optimization, with particular attention to improving patient selection criteria and procedural techniques. Her work on cost-effectiveness of cardiac device interventions demonstrates her commitment to understanding the broader healthcare implications of electrophysiology treatments.

• Cardiac Electrophysiology
• Arrhythmia Management
• Cardiac Resynchronization Therapy
• +۶ مورد دیگر

Dr. Mark Hoogendijk is a Researcher in the Department of Cardiology at Erasmus University Medical Center (Erasmus MC) in Rotterdam, the Netherlands, specializing in cardiac electrophysiology with a focus on atrial fibrillation mechanisms and ablation therapies. His primary research interests include: Atrial Fibrillation Heart Ventricle Arrhythmia Pulmonary Vein Isolation Recurrent Disease Persistent Atrial Fibrillation ST Elevation Brugada Syndrome Radiofrequency Ablation Recent publications (2024-2025) demonstrate a concentrated effort to optimize ablation techniques through engineering innovations and clinical validation. Key trends include development of hexagonal multielectrode systems for superior electrogram recording, size-adjustable cryoballoons for precise pulmonary vein isolation, and high-power short-duration radiofrequency protocols that rival cryoablation efficacy. His work with the AF-FLOW Global Registry establishes electrographic flow mapping as a critical phenotyping tool, while device infection risk stratification research addresses post-implant complications. No documented scientific awards are currently associated with his profile. Dr. Hoogendijk actively collaborates in international research networks including the AF-FLOW Global Registry consortium. His 36 research outputs reveal extensive co-authorship with Erasmus MC colleagues across cardiology, electrophysiology, and biomedical engineering disciplines, though specific grant funding details remain unreported. Current work centers on translational projects bridging cardiac mapping technology with clinical ablation workflows.

• Atrial Fibrillation
• Heart Ventricle Arrhythmia
• Pulmonary Vein Isolation
• +۵ مورد دیگر

Ralph DeBiasi, MD, is an Assistant Professor of Medicine (Cardiovascular Medicine) at Yale School of Medicine. He specializes in cardiac electrophysiology, focusing on the diagnosis and treatment of heart rhythm abnormalities, particularly atrial fibrillation. Dr. DeBiasi emphasizes patient-centered care, prioritizing shared decision-making to ensure patients understand their conditions and treatment options. He is affiliated with the Cardiovascular Medicine Electrophysiology & Cardiac Arrhythmia Program and holds academic appointments in the Department of Medicine. Education & Training: MD: The Mount Sinai School of Medicine (2010) Residency: Massachusetts General Hospital/Harvard Medical School (2013) Fellowship in Cardiology & Electrophysiology: Yale University (2017) Research & Clinical Focus: Dr. DeBiasi’s work centers on advancing therapies for atrial fibrillation and optimizing patient outcomes through cutting-edge electrophysiology techniques. He is actively involved in evaluating new technologies for managing heart rhythm disorders and improving quality of life for patients. His clinical interests include implantable devices (e.g., defibrillators, pacemakers) and minimally invasive surgical approaches. Awards: Alpha Omega Alpha Honor Medical Society (2010) Clinical Affiliations: Dr. DeBiasi practices at multiple Yale Medicine locations, including Lawrence + Memorial Physicians - Cardiology (Waterford, CT) and Wawecus Medical Center (Norwich, CT). He accepts new patients and offers telehealth consultations.

• Cardiac Electrophysiology
• Atrial Fibrillation Management
• Heart Rhythm Disorders
• +۳ مورد دیگر

Joshua Cooper, MD, is a Professor of Medicine at the Lewis Katz School of Medicine at Temple University and serves as the Director of Cardiac Electrophysiology at Temple University Hospital. He specializes in complex arrhythmia management, catheter ablation, and the use of advanced implantable cardiac devices. Education: MD, Washington University School of Medicine, St. Louis, MO Fellowship, Cardiac Electrophysiology, Brigham and Women’s Hospital, Boston, MA Fellowship, Cardiology, Brigham and Women’s Hospital, Boston, MA Residency, Internal Medicine, Brigham and Women’s Hospital, Boston, MA His research interests include catheter ablation for atrial fibrillation and ventricular tachycardia, implantable defibrillators, His-bundle pacing, laser lead extraction, and arrhythmias in conditions like sarcoidosis and myotonic dystrophy. He emphasizes patient education and shared decision-making in clinical care. His recent publications focus on device therapy, ablation outcomes, and electrophysiological substrate mapping, with a strong emphasis on improving clinical outcomes in complex arrhythmias. Trends in his work include the optimization of device programming, management of device infections, and the use of imaging and novel algorithms in electrophysiology. Scientific Awards and Honors: Top Doctors, Cardiac Electrophysiology, Philadelphia magazine (2011–2025) Best Doctors in America® (2015–2020) Fellow, American College of Cardiology (FACC) Fellow, Heart Rhythm Society (FHRS) Outstanding Subspecialty Faculty Educator Award, Temple University Distinguished Teaching Awards from University of Pennsylvania and Temple Multiple academic honors from Harvard and Washington University Dr. Cooper has been actively involved in multicenter studies, consensus guidelines, and clinical innovation in cardiac electrophysiology. He has contributed to research on lead extraction, sarcoidosis, and device interactions. He also participates in public education, including media appearances such as the ‘Higher Learning’ podcast discussing Damar Hamlin’s cardiac arrest. His leadership in both clinical and academic domains underscores his significant impact in cardiovascular medicine. He practices at the Temple Heart & Vascular Institute in Philadelphia and continues to be a leading figure in electrophysiology research and patient care.

• Cardiac Electrophysiology
• Arrhythmia Management
• Catheter Ablation
• +۱۷ مورد دیگر

Dr. Atul Verma is a Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) at the Montreal General Hospital site, where he is affiliated with the Cardiovascular Health Across the Lifespan Program and the Centre for Outcomes Research and Evaluation. He serves as an Associate Professor in the Department of Medicine within the Faculty of Medicine and Health Sciences at McGill University. His work bridges clinical practice and research in cardiac electrophysiology, with a focus on innovative treatments for heart rhythm disorders. Dr. Verma is a cardiologist and cardiac electrophysiologist specializing in heart rhythm disturbances called arrhythmias. His research primarily focuses on interventional solutions for treating arrhythmias, including pacemaker or defibrillator implantation and catheter ablation. He is actively involved in several clinical trials investigating new techniques and technologies for catheter ablation of atrial fibrillation and ventricular tachycardia. His translational laboratory work evaluates emerging ablation technologies such as pulsed field ablation, ultra-low temperature cryoablation, and needle ablation. Dr. Verma's recent research has centered on advancing pulsed field ablation techniques for atrial fibrillation treatment. His work spans from basic laboratory investigations to large multicenter clinical trials, including the PULSED AF, ADVANTAGE AF, and inspIRE trials. His research explores personalized approaches to ablation, incorporating artificial intelligence and novel mapping techniques to improve outcomes, particularly for persistent atrial fibrillation cases where conventional approaches have limitations. Dr. Verma has made significant contributions to the field through numerous high-impact publications in leading journals including the New England Journal of Medicine, JAMA, and Circulation. His research has significantly influenced clinical practice guidelines for atrial fibrillation management. As a Senior Scientist at RI-MUHC, Dr. Verma leads a research team focused on translational cardiac electrophysiology. His laboratory investigates novel ablation technologies and their mechanisms of action, working closely with clinical teams to rapidly translate findings into patient care. He collaborates extensively with international research groups on multicenter clinical trials evaluating new arrhythmia treatments.

• arrhythmias
• atrial fibrillation
• ventricular tachycardia
• +۵ مورد دیگر

Sanket Dhruva, MD, MHS is an Associate Professor in the Department of Medicine at the University of California, San Francisco (UCSF) School of Medicine. He completed his medical training at UCSF, followed by a cardiology fellowship at UC Davis, and an MHS through the Robert Wood Johnson Foundation Clinical Scholars Program at Yale University. Dr. Dhruva's work focuses on medical device and drug safety, regulation, and evidence generation, with particular expertise in cardiovascular devices and Medicare coverage policies. Education BA in Molecular & Cell Biology and Political Science from UC Berkeley (2005) MD from UCSF School of Medicine (2009) Internal Medicine Residency at UCSF Department of Medicine (2012) Cardiology Fellowship at UC Davis Division of Cardiovascular Medicine (2015) MHS through Robert Wood Johnson Foundation Clinical Scholars Program at Yale University (2017) LEAN Champion training at UCSF (2019) Diversity, Equity, and Inclusion Champion Training at UCSF (2021) Research Interests Dr. Dhruva's research spans several interconnected areas centered around medical device and drug safety, regulation, and evidence generation. His work examines FDA approval processes for high-risk medical devices, Medicare coverage determinations, and the generation of real-world evidence to inform clinical practice and policy decisions. A significant portion of his research focuses on cardiovascular devices, including pacemakers, implantable cardioverter-defibrillators, and transcatheter valve technologies. He investigates safety concerns, appropriate utilization, and regulatory pathways for these devices. His work often involves large dataset analyses to evaluate device performance in real-world settings. Dr. Dhruva also studies Medicare formulary coverage policies, particularly how coverage decisions are made for novel drugs and devices, and the implications for patient access and healthcare costs. His research on the Medicare Coverage with Evidence Development program has been particularly influential in understanding how evidence generation requirements impact coverage decisions. Publication Trends Dr. Dhruva's recent publications (2023-2025) demonstrate a continued focus on medical device regulation, safety, and evidence generation. His work spans multiple high-impact journals including JAMA, New England Journal of Medicine, and Journal of the American College of Cardiology. A notable trend is increased attention to remote monitoring of cardiovascular implantable electronic devices, artificial intelligence applications in cardiology, and the implications of Medicare payment policies for medical technologies. His research shows growing interest in health equity considerations for medical device development and use, as evidenced by recent publications on challenges and solutions for advancing health equity with medical devices. There's also a clear pattern of examining how regulatory decisions impact clinical practice, with particular attention to the FDA's Breakthrough Devices Program and Unique Device Identifier implementation. Professional Activities Dr. Dhruva maintains active collaborations with the Veterans Health Administration on research related to cardiovascular device monitoring. His work often involves multi-institutional teams spanning UCSF, Yale, and other academic medical centers. He serves as a reviewer for major medical journals and contributes to policy discussions regarding medical device regulation and evidence generation.

• Medical Device and Drug Safety
• Medical Device Regulation and Insurer Coverage
• Real-World Evidence
• +۵ مورد دیگر

Rohit Bhagwandien is a researcher in the Department of Cardiology at Erasmus School of Medicine , Erasmus University Rotterdam. His work focuses on interventional electrophysiology and device-based therapies for cardiac arrhythmias. Primary Affiliation: Erasmus University Rotterdam (Erasmus MC) Department: Cardiology Research interests include Atrial Fibrillation , Pulmonary Vein Isolation , Cryoablation , and Medical Devices for cardiac rhythm management. His studies address procedural optimization and risk stratification in device implantation and ablation therapies. Recent publications highlight innovations in balloon occlusion technology and high-power radiofrequency ablation , comparative effectiveness of ablation techniques, and risk assessment in device infections . Collaborative work spans arrhythmia mechanisms in ischemic heart disease . Current affiliations include multidisciplinary collaborations within the Erasmus MC network, focusing on clinical trials and translational research in cardiac electrophysiology.

• Cardiology
• Electrophysiology
• Interventional Cardiology
• +۳ مورد دیگر

Eric Grubman, MD, is an Associate Professor of Cardiovascular Medicine at Yale School of Medicine and Director of Ambulatory Electrophysiology in Internal Medicine. He specializes in cardiac electrophysiology, focusing on arrhythmias, pacemakers, and defibrillators. He completed his MD at Georgetown University, residency at Mount Sinai Hospital, and fellowships in Cardiology and Electrophysiology at the University of Pennsylvania. Dr. Grubman is a pioneer in leadless pacemaker implantation and has authored numerous studies on cardiac devices. His research emphasizes long-term outcomes of transcatheter pacing systems and minimally invasive approaches. He holds leadership roles in professional organizations like the Heart Rhythm Society and contributes to clinical trials and device innovation. His clinical expertise includes biventricular pacing optimization and care for patients with complex cardiac histories. Education: BA Biochemistry (Dartmouth College), MS Human Physiology (Georgetown), MD (Georgetown), Residency (Mount Sinai), Fellowships (University of Pennsylvania). Key Roles: Director of Ambulatory Electrophysiology, Yale Medicine Cardiac Electrophysiology Program. Research interests span pacemaker technology, arrhythmia management, and transcatheter device advancements. He collaborates on studies evaluating device efficacy and patient outcomes, with a focus on improving care for those with chronic heart conditions.

• Cardiac Electrophysiology
• Pacemaker Technology
• Cardiac Arrhythmias
• +۳ مورد دیگر

Mark Schoenfeld, MD, is a Clinical Professor of Medicine in the Department of Cardiovascular Medicine at Yale School of Medicine and Professor at Frank H. Netter MD School of Medicine, Quinnipiac University. He has spent nearly two decades at Yale, pioneering cardiac electrophysiology and establishing electrophysiology labs at multiple hospitals. A Harvard Medical School graduate, Dr. Schoenfeld completed residency and fellowship at Massachusetts General Hospital, including one of the earliest cardiac electrophysiology programs. Board Certifications: Cardiovascular Disease (ABIM, 1985), Internal Medicine (ABIM, 1982) Leadership: Past President of Heart Rhythm Society, Governor of Connecticut ACC chapter Dr. Schoenfeld specializes in diagnosing and treating cardiac arrhythmias through electrophysiology studies, ablation, and device implantation (pacemakers, defibrillators). His research focuses on advancing device therapy and remote monitoring, with significant contributions to ACC/AHA/HRS clinical guidelines for managing rhythm disturbances. He actively engages in healthcare policy through FDA and CMS advisory roles. Recent publications highlight his work on urgent arrhythmia protocols, device complications, and guideline development. His clinical trials have shaped advancements in implantable cardioverter-defibrillator technology and catheter ablation over three decades. Scientific awards include Fellowships from Heart Rhythm Society, American Heart Association, and Yale-based clinical leadership recognition. He serves on the AMA’s RUC committee and reviews for major journals like the American Journal of Cardiology.

• Cardiac Electrophysiology
• Arrhythmia Management
• Pacemaker and Defibrillator Therapy
• +۳ مورد دیگر

Jacob Mosgaard Larsen is a Clinical Associate Professor at Aalborg University Hospital, affiliated with the Department of Clinical Medicine and Department of Cardiology within the Faculty of Medicine. His research focuses on cardiology, particularly atrial fibrillation, cardiac devices, and digital health technologies. He has published extensively since 2009, with recent work addressing physician preferences for digital devices in arrhythmia management and the role of omega-3 fatty acids in reducing atrial fibrillation risk. Education & Affiliations: Aalborg University Hospital, Department of Cardiology, Faculty of Medicine. Research Interests: Atrial Fibrillation, Cardioversion, Defibrillator Technology, Digital Health, Nutrition and Cardiac Health. His studies often involve collaborations on cohort analyses and device safety in clinical settings. Grants & Advising: Supervised 3 PhD students. Active in creating datasets on interval-censored regression models for medical outcomes. Labs & Teams: Engaged in clinical and experimental research teams focusing on cardiac electrophysiology and device innovation.

• Cardiology
• Electrophysiology
• Atrial Fibrillation
• +۴ مورد دیگر

Annette Ross Jakobsen serves as Cheffysiker (Chief Physician) at Aalborg University Hospital within The Faculty of Medicine , specifically the Department of Oncology . Her position bridges clinical oncology practice and academic research at Aalborg University. Her research focuses on the critical intersection of Radiation Therapy and Implantable Cardiac Devices , addressing safety protocols for cancer patients with pacemakers/ICDs. Key areas include radiation-induced device malfunction risks, precision radiotherapy techniques for head/neck cancers, and medical physics innovations in treatment calibration. Her work directly impacts clinical guidelines for cardio-oncology safety. Analysis of her recent publications (2015-2024) reveals consistent specialization in radiation-device interactions, with emphasis on population-based risk assessment and technical solutions for treatment accuracy. Her fingerprint shows dominant expertise in Radiation Therapy (100%) and Implantable Automatic Defibrillator safety (86%). Dr. Jakobsen actively collaborates with medical physicists and cardiologists, evidenced by multi-disciplinary publications in journals like Pacing and Clinical Electrophysiology and Radiotherapy & Oncology . Her research has been referenced in clinical guidelines and garnered significant academic attention with 91 Scopus citations for key cohort studies. She operates within Aalborg University Hospital's oncology infrastructure, contributing to technical advancements like surface-guided repositioning systems and ExacTrac X-ray calibration methods. Current work focuses on optimizing radiotherapy safety protocols for cardiac device patients through both clinical studies and technical innovations.

• Radiation Therapy
• Implantable Cardiac Devices
• Oncology
• +۳ مورد دیگر